Latest News & Updates
Breaking News
19 hours ago
Simantini Singh Deo
Other trending news you may like to read
Axcelead Presents Multi-Cell-Line Proteomics Platform for TPD Off-Target Safety Assessment at JSOT 2026
Axcelead presents a multi-cell-line proteomics platform for TPD off-target safety assessment at JSOT 2026, detecting ~10,000 proteins across a human-derived panel.
Simantini Singh Deo
Teva Submits NDA for Ecopipam as First-in-Class Pediatric Tourette Therapy After Phase 3 Win
Teva files NDA for ecopipam, a D1 receptor antagonist with Orphan Drug and Fast Track status, targeting pediatric Tourette syndrome.
Simantini Singh Deo
Novartis Gene Therapies Receives Ninth FDA Approval Letter for Zolgensma Under BLA 125694
FDA issues a ninth approval letter for Zolgensma under BLA 125694, extending Novartis Gene Therapies' post-market compliance obligations.
Simantini Singh Deo
Essential Pharma Appoints Becki Morison as CEO, Effective 1 July 2026
Becki Morison takes the CEO role at Essential Pharma on 1 July 2026, bringing rare disease and specialty pharma commercial leadership from LEO Pharma and Eli Lilly.
Simantini Singh Deo
